ATLASRevolution Medicines (RVMD) earnings date: Nov 4, 2026
Revolution Medicines (RVMD) reports earnings for the quarter ended Sep 30, 2026 on Wed, Nov 4, 2026, after the close. Analysts expect EPS of -$2.34.
Source: company filings and exchange data · Updated Nov 2, 2026
Revolution Medicines reports on Nov 4, 2026. One email the day before, with ATLAS’s read on Revolution Medicines. You can switch it off at any time.
Alert me before RVMD reportsFree to start. Creating an account takes under a minute.
RVMD earnings at a glance
| Next report (confirmed) | Wed, Nov 4, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$2.34 |
| Last report | Aug 5, 2026 · Miss |
| Beat rate (last 4 reports) | 3 of 4 (75%) |
| Average EPS surprise | -2.8% |
| Average move around a report | ±3.9% (last 4) |
| Sector | Healthcare · Biotechnology |
Revolution Medicines earnings history: last 4 reports
Revolution Medicines last reported on Aug 5, 2026: EPS of -$3.06 against an estimate of -$2.06 (-48.5% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 5, 2026 | -$2.06 | -$3.06 | -48.5% | Miss | +2.3% |
| May 29, 2026 | $0.74 | $0.92 | +24.3% | Beat | +5.9% |
| May 20, 2026 | $2.91 | $3.09 | +6.2% | Beat | +4.4% |
| May 6, 2026 | $2.55 | $2.72 | +6.7% | Beat | -3.2% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
ATLAS view on RVMD before the report
| Last price | $191.31 (+0.6%) |
|---|---|
| ATLAS chance of a higher price in 1 month | 49% |
| Likely 1-month range (50%) | $175.87 – $206.72 |
| Normal 1-day range (±1σ) | ±2.8% |
These figures come from the same calibrated model and valuation as the Revolution Medicines stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Get the full ATLAS analysis for RVMD
See the fair value, the probability range and the earnings history of Revolution Medicines on its ATLAS page.
Revolution Medicines (RVMD) stock analysisPlans from €3.99 a month.
Revolution Medicines earnings: frequently asked questions
When does Revolution Medicines (RVMD) report earnings?
Revolution Medicines is scheduled to report on Wednesday, November 4, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for RVMD?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$2.34 per share (USD). Estimates can change before the report.
How often does RVMD beat earnings estimates?
Of its last 4 reports with a recorded result, Revolution Medicines beat the EPS estimate 3 times; the average surprise was -2.8%. Past results do not predict the next one.
How much does RVMD move around earnings?
Over its last 4 reports the stock moved an average of 3.9% (absolute, from the close before the report day to the close after it), and finished higher 3 of 4 times.
Did Revolution Medicines beat earnings estimates last quarter?
Revolution Medicines last reported on Aug 5, 2026: EPS of -$3.06 against an estimate of -$2.06 (-48.5% surprise), a miss.
How much does RVMD usually move in a day?
On a normal trading day the ATLAS model puts RVMD’s one-day range at about ±2.8%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Wed, Nov 4, 2026
Educational information, not investment advice. Disclaimer